We are live on ! Find out more
ASPX

AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX

Delisted

ASPX was delisted on the 4th of May, 2015.

Back to rankings

89 hedge funds and large institutions have $773M invested in AUSPEX PHARMACEUTICALS INC COM STK (DE) in 2014 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 22 increasing their positions, 22 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding in top 10

Funds holding in top 10: 2 → 5 (+3)

149% more capital invested

Capital invested by funds: $310M → $773M (+$463M)

95% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 19

25% more funds holding

Funds holding: 71 → 89 (+18)

0% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 22

Holders
89
Holders Change
+18
Holders Change %
+25.35%
% of All Funds
2.37%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.13%
New
37
Increased
22
Reduced
22
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$42.7M
2
DM
Deerfield Management
New York
+$12.8M
3
BFA
BlackRock Fund Advisors
California
+$10.6M
4
Jennison Associates
Jennison Associates
New York
+$8.97M
5
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$8.64M

Top Sellers

Rank Fund Capital Flow
1
Ameriprise
Ameriprise
Minnesota
-$7.57M
2
VAM
Visium Asset Management
New York
-$4.71M
3
Millennium Management
Millennium Management
New York
-$3.77M
4
EA
Emerald Advisers
Pennsylvania
-$2.8M
5
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
-$2.62M
Name Holding Trade Value Shares
Change 		Change in
Stake
O
26
OrbiMed
New York
$4.91M +$2.75M +93,600 New
Geode Capital Management
27
Geode Capital Management
Massachusetts
$3.9M +$38.2K +1,301 +2%
DCM
28
Driehaus Capital Management
Illinois
$3.6M +$56.9K +1,938 +3%
ACA
29
Apis Capital Advisors
New York
$3.41M +$1.91M +65,000 New
ECM
30
Endurant Capital Management
California
$2.83M +$1.58M +53,950 New
TCIM
31
TIAA CREF Investment Management
New York
$2.62M +$22.3K +760 +2%
State of New Jersey Common Pension Fund D
32
State of New Jersey Common Pension Fund D
New Jersey
$2.28M – – –
T. Rowe Price Associates
33
T. Rowe Price Associates
Maryland
$2.12M +$1.19M +40,359 New
GPCM
34
Granite Point Capital Management
Massachusetts
$1.89M -$117K -4,000 -10%
CS
35
Credit Suisse
Switzerland
$1.65M +$652K +22,215 +241%
SKK
36
Shepherd Kaplan Krochuk
Massachusetts
$1.48M – – –
BIM
37
BlackRock Investment Management
Delaware
$1.42M -$3.08K -105 -0.4%
BC
38
Birchview Capital
Vermont
$1.34M +$749K +25,500 New
FM
39
Forward Management
California
$1.29M +$1.6M +54,476 New
Charles Schwab
40
Charles Schwab
California
$1.26M +$25.1K +854 +4%
D.E. Shaw & Co
41
D.E. Shaw & Co
New York
$1.14M +$638K +21,737 New
Invesco
42
Invesco
Georgia
$1.11M +$619K +21,071 New
ProShare Advisors
43
ProShare Advisors
Maryland
$1.06M +$595K +20,263 New
GTC
44
Ghost Tree Capital
New York
$1.05M +$587K +20,000 New
KCM
45
Knoll Capital Management
Florida
$1.05M +$587K +20,000 New
Deutsche Bank
46
Deutsche Bank
Germany
$1.02M +$262K +8,907 +84%
Morgan Stanley
47
Morgan Stanley
New York
$964K +$491K +16,720 +1,013%
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$906K +$2.14K +73 +0.4%
SOMRS
49
State of Michigan Retirement System
Michigan
$892K +$499K +16,997 New
CCI
50
Columbus Circle Investors
$838K +$469K +15,976 New
1
2
3 4 5

ASPX Hedge Fund Activity: Q4 2014 in Review

89 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) for Q4 2014, worth a combined $773M — up 149% from $310M a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new ASPX positions and 19 closed out — a net gain of 18 holders — while 22 added to existing stakes and 22 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $42.7M. The largest seller was Ameriprise, cutting an estimated $7.57M.

  • 89 institutional investors held AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) as of Q4 2014, up from 71 in Q3 2014.
  • Funds reported $773M of AUSPEX PHARMACEUTICALS INC COM STK (DE) stock for Q4 2014, up 149% quarter-over-quarter.
  • 37 funds opened new AUSPEX PHARMACEUTICALS INC COM STK (DE) positions in Q4 2014 and 19 closed out, a net change of +18 holders.
  • The largest AUSPEX PHARMACEUTICALS INC COM STK (DE) buyer in Q4 2014 was Fidelity Investments, an estimated $42.7M added.
  • The largest AUSPEX PHARMACEUTICALS INC COM STK (DE) seller in Q4 2014 was Ameriprise, an estimated $7.57M sold.

Based on aggregated 13F filings for Q4 2014.